Platelet MicroRNAs: An Overview

Transfusion Medicine Reviews

Volumn 29, Issue 4, 2015, Pages 215-219

  Dahiya, Neetu ^a   Sarachana, Tewarit ^b   Vu, Long ^a   Becker, Kevin G ^c   Wood, William H ^c   Zhang, Yongqing ^c   Atreya, Chintamani D ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Blood disorders; MicroRNA; Platelets; Signaling pathways

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 125; MICRORNA 126; MICRORNA 140; MICRORNA 145; MICRORNA 150; MICRORNA 154; MICRORNA 16; MICRORNA 199; MICRORNA 223; MICRORNA 26B; MICRORNA 326; MICRORNA 329; MICRORNA 376; MICRORNA 7; MICRORNA 96; MICRORNA LET 7; MICRORNA LET 7B; UNCLASSIFIED DRUG; GENETIC MARKER;

DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; PATHOGEN CLEARANCE; PLATELET REACTIVITY; QUALITY CONTROL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE DISORDER; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; ANIMAL; BLOOD PLATELET DISORDERS; BLOOD STORAGE; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; BLOOD PRESERVATION; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84941933148     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2015.08.002     Document Type: Review

References (44)

1. Eulalio A., Huntzinger E., Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008, 132:9-14.
2. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
3. Shivdasani R.A. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006, 108:3646-3653.
4. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008, 14:27-41.
5. De Santis G., Ferracin M., Biondani A., Caniatti L., Rosaria Tola M., Castellazzi M., et al. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 2010, 226:165-171.
6. Li X., Shi Y., Yin Z., Xue X., Zhou B. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma. J Transl Med 2014, 12:1-12. [159].
7. Buckland J. Biomarkers: microRNAs under the spotlight in inflammatory arthritis. Nat Rev Rheumatol 2010, 6:1-20[436].
8. Holcomb J.B., Tilley B.C., Baraniuk S., Fox E.E., Wade C.E., Podbielski J.M., et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015, 313:471-482. PROPPR Study Group.
9. Romania P., Lulli V., Pelosi E., Biffoni M., Peschle C., Marziali G. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol 2008, 143:570-580.
10. Ben-Ami O., Pencovich N., Lotem J., Levanon D., Groner Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. PNAS 2009, 106:238-243.
11. Labbaye C., Spinello I., Quaranta M.T., Pelosi E., Pasquini L., Petrucci E., et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 2008, 10:788-801.
12. Lazare S.S., Wojtowicz E.E., Bystrykh L.V., de Haan G. microRNAs in hematopoiesis. Exp Cell Res 2014, 329:234-238.
13. Montagner S., Deho L., Monticelli S. MicroRNAs in hematopoietic development. BMC Immunol 2014, 15:14-25.
14. Undi R.B., Kandi R., Gutti R.K. MicroRNAs as haematopoiesis regulators. Adv Hematol 2013, 2013:1-20. [695754].
15. Garzon R., Pichiorri F., Palumbo T., Iuliano R., Cimmino A., Aqeilan R., et al. MicroRNA fingerprints during human megakaryocytopoiesis. PNAS 2006, 103:5078-5083.
16. Lu J., Guo S., Ebert B.L., Zhang H., Peng X., Bosco J., et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008, 14:843-853.
17. Navarro F., Gutman D., Meire E., Cáceres M., Rigoutsos I., Bentwich Z., et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 2009, 114:2181-2192.
18. Yuan J.Y., Wang F., Yu J., Yang G.H., Liu X.L., Zhang J.W. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 2009, 13:4551-4559.
19. Landry P., Plante I., Ouellet D.L., Perron M.P., Rousseau G., Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009, 16:961-966.
20. Ple H., Landry P., Benham A., Coarfa C., Gunaratne P.H., Provost P. The repertoire and features of human platelet microRNAs. PLoS One 2012, 7:1-14. [e50746].
21. Simon L.M., Edelstein L.C., Nagalla S., Woodley A.B., Chen E.S., Kong X., et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014, 123:e37-e45.
22. Yu S., Deng G., Qian D., Xie Z., Sun H., Huang D., et al. Detection of apoptosis-associated microRNA in human apheresis platelets during storage by quantitative real-time polymerase chain reaction analysis. Blood Transfus 2014, 12:541-547.
23. Yu S., Huang H., Deng G., Xie Z., Ye Y., Guo R., et al. miR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets. PLoS One 2015, 10:1-14. [e0122784].
24. Kannan M., Mohan K.V., Kulkarni S., Atreya C. Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 2009, 49:1443-1450.
25. Rosado J.A., Meijer E.M., Hamulyak K., Novakova I., Heemskerk J.W., Sage S.O. Fibrinogen binding to the integrin alpha(IIb)beta(3) modulates store-mediated calcium entry in human platelets. Blood 2001, 97:2648-2656.
26. Schubert P., Thon J.N., Walsh G.M., Chen C.H., Moore E.D., Devine D.V., et al. A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009, 49:1944-1955.
27. Bruchova H., Merkerova M., Prchal J.T. Aberrant expression of microRNA in polycythemia vera. Haematologica 2008, 93:1009-1016.
28. Kondkar A.A., Bray M.S., Leal S.M., Nagalla S., Liu D.J., Jin Y., et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 2010, 8:369-378.
29. Goren Y., Meiri E., Hogan C., Mitchell H., Lebanony D., Salman N., et al. Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. Am J Cardiol 2014, 113:976-981.
30. Jain S., Kapetanaki M.G., Raghavachari N., Woodhouse K., Yu G., Barge S., et al. Expression of regulatory platelet microRNAs in patients with sickle cell disease. PLoS One 2013, 8:1-13. [e60932].
31. Shi R., Zhou X., Ji W.J., Zhang Y.Y., Ma Y.Q., Zhang J.Q., et al. The emerging role of miR-223 in platelet reactivity: implications in antiplatelet therapy. Biomed Res Int 2015, 2015:1-8. [981841].
32. Horstman L.L., Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999, 30:111-142.
33. Mause S.F., Weber C. Protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057.
34. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:1-13. [e3694].
35. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., Marquez-Curtis L., Machalinski B., Ratajczak J., et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005, 113:752-760.
36. Diehl P., Fricke A., Sander L., Stamm J., Bassler N., Htun N., et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012, 93:633-644.
37. Gatsiou A., Boeckel J.N., Randriamboavonjy V., Stellos K. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr Vasc Pharmacol 2012, 10:524-531.
38. Semple J.W. Platelets deliver small packages of genetic function. Blood 2013, 122:155-156.
39. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
40. Laffont B., Corduan A., Ple H., Duchez A.C., Cloutier N., Boilard E., et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013, 122:253-261.
41. Pan Y., Liang H., Liu H., Li D., Chen X., Li L., et al. Platelet secreted MicroRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol 2014, 192:437-446.
42. Castrillo A., Cardoso M., Rouse L. Treatment of buffy coat platelets in platelet additive solution with the mirasol((R)) pathogen reduction technology system. Transfus Med Hemother 2013, 40:44-48.
43. Abedi M.R., Doverud A.C. Preparation and pathogen inactivation of double dose buffy coat platelet products using the INTERCEPT blood system. J Vis Exp 2012, 70:1-8. [e4414].
44. Osman A., Hitzler W.E., Meyer C.U., Landry P., Corduan A., Laffont B., et al. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets 2015, 26:154-163.